Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin in Chinese Subjects With Impaired Glucose Tolerance
NCT00961363Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Dec 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in impaired glucose tolerance (IGT) comparing Sitagliptin with Placebo (2 arms). Primary endpoint: Change in fasting and post-load plasma glucose levels during OGTT at 24 weeks. Status: unknown.
02
Drugs
sitagliptin
03
Conditions
impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00961363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00961363.